Dumesnil Simon
SEC insider (Form 3/4/5 filer). CIK 0001875691. Director at Pasithea Therapeutics Corp. (KTTA). 3 reported Form 4/5 transactions since Sep 2024; latest on May 1, 2026. Located in MIAMI BEACH, FL.
Companies Dumesnil Simon has filed insider reports for
- Pasithea Therapeutics Corp. (KTTA): Director
Dumesnil Simon
CIK: 0001875691
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KTTA
Pasithea Therapeutics Corp.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- May 1, 2026KTTA
Pasithea Therapeutics Corp.
AwardDirectStock Option (right to buy)
152.8K shares- - Nov 28, 2025KTTA
Pasithea Therapeutics Corp.
PurchaseDirect33.3K shares at avg. $0.75$25K - Oct 24, 2025KTTA
Pasithea Therapeutics Corp.
AwardDirectStock Option (right to buy)
42.9K shares-
1-3 of 3 transactions